Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley

Background: Pancreaticoduodenectomy provides the only opportunity to cure resectable and borderline pancreatic ductal adenocarcinoma. This is linked to a high rate of morbidity and mortality, especially when combined with hepatic artery anomalies. The goal of this study was to analyse the spectrum a...

Full description

Bibliographic Details
Main Authors: Nayeem Ul Hassan, Yaqoob Hassan, Prince Ajaz Ahmad, Omar Javed Shah, Mohamad Younis Bhat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Medical Journal of Babylon
Subjects:
Online Access:http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2022;volume=19;issue=3;spage=350;epage=353;aulast=Hassan
_version_ 1797995503641690112
author Nayeem Ul Hassan
Yaqoob Hassan
Prince Ajaz Ahmad
Omar Javed Shah
Mohamad Younis Bhat
author_facet Nayeem Ul Hassan
Yaqoob Hassan
Prince Ajaz Ahmad
Omar Javed Shah
Mohamad Younis Bhat
author_sort Nayeem Ul Hassan
collection DOAJ
description Background: Pancreaticoduodenectomy provides the only opportunity to cure resectable and borderline pancreatic ductal adenocarcinoma. This is linked to a high rate of morbidity and mortality, especially when combined with hepatic artery anomalies. The goal of this study was to analyse the spectrum and impact of hepatic artery anomalies on intraoperative and postoperative variables, and oncologic outcomes in patients undergoing pancreaticoduodenectomy. Materials and Methods: All patients with resectable periampullary or pancreatic head tumours who underwent pancreaticoduodenectmy (PD) were included. Patients were divided into two groups using computer-generated random numbers; Group A included patients who had pancreaticoduodenectmy (PD) with normal hepatic artery anatomy and Group B included patients with aberrant hepatic artery anatomy. The data was collected and analysed using SPSS 22. Results: Among the 238 patients who met the inclusion criteria, 177(74.36%) participants were included in Group A (Normal hepatic artery anatomy) and 61 (25.36%) in Group B (Aberrant hepatic artery anatomy). The mean age of patients in Group A was 51.3 ± 8.63 years while it was 50.6 ± 8.09 years in Group B. The difference in gender, BMI, pre-operative haemoglobin, bilirubin and albumin between two groups was statistically insignificant (P value >0.05). The difference in mean operative time of Group A 230.9(168–390) minutes and Group B 319.6(200–620) minutes was statistically significant (p-value <0.001). The mean blood loss in Group A (511.5 120.18 ml) was significantly lower than in Group B (623.6 127.06 ml) (P ≤ 0.001). There were no significant differences between the two groups in terms of post-operative pancreatic fistula, delayed gastric emptying, wound infection, atelectasis, hospital stay, peri-operative mortality, positive resection margins, and mean lymph node yield. Conclusion: Patients with hepatic artery anomalies who undergo pancreaticoduodenectomy have significantly more operative blood loss. This could be due to the procedure’s complexity and lengthy operative time. There were no differences between the two groups in terms of postoperative morbidity, oncological outcome, or mortality.
first_indexed 2024-04-11T10:02:47Z
format Article
id doaj.art-5598c52ca9f444b882e11334742c9e58
institution Directory Open Access Journal
issn 1812-156X
2312-6760
language English
last_indexed 2024-04-11T10:02:47Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj.art-5598c52ca9f444b882e11334742c9e582022-12-22T04:30:20ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602022-01-0119335035310.4103/MJBL.MJBL_4_22Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir ValleyNayeem Ul HassanYaqoob HassanPrince Ajaz AhmadOmar Javed ShahMohamad Younis BhatBackground: Pancreaticoduodenectomy provides the only opportunity to cure resectable and borderline pancreatic ductal adenocarcinoma. This is linked to a high rate of morbidity and mortality, especially when combined with hepatic artery anomalies. The goal of this study was to analyse the spectrum and impact of hepatic artery anomalies on intraoperative and postoperative variables, and oncologic outcomes in patients undergoing pancreaticoduodenectomy. Materials and Methods: All patients with resectable periampullary or pancreatic head tumours who underwent pancreaticoduodenectmy (PD) were included. Patients were divided into two groups using computer-generated random numbers; Group A included patients who had pancreaticoduodenectmy (PD) with normal hepatic artery anatomy and Group B included patients with aberrant hepatic artery anatomy. The data was collected and analysed using SPSS 22. Results: Among the 238 patients who met the inclusion criteria, 177(74.36%) participants were included in Group A (Normal hepatic artery anatomy) and 61 (25.36%) in Group B (Aberrant hepatic artery anatomy). The mean age of patients in Group A was 51.3 ± 8.63 years while it was 50.6 ± 8.09 years in Group B. The difference in gender, BMI, pre-operative haemoglobin, bilirubin and albumin between two groups was statistically insignificant (P value >0.05). The difference in mean operative time of Group A 230.9(168–390) minutes and Group B 319.6(200–620) minutes was statistically significant (p-value <0.001). The mean blood loss in Group A (511.5 120.18 ml) was significantly lower than in Group B (623.6 127.06 ml) (P ≤ 0.001). There were no significant differences between the two groups in terms of post-operative pancreatic fistula, delayed gastric emptying, wound infection, atelectasis, hospital stay, peri-operative mortality, positive resection margins, and mean lymph node yield. Conclusion: Patients with hepatic artery anomalies who undergo pancreaticoduodenectomy have significantly more operative blood loss. This could be due to the procedure’s complexity and lengthy operative time. There were no differences between the two groups in terms of postoperative morbidity, oncological outcome, or mortality.http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2022;volume=19;issue=3;spage=350;epage=353;aulast=Hassanpancreatoduodenectomyaberrant right hepatic arterysurgical complicationpostoperative pancreatic fistulasoncological outcome
spellingShingle Nayeem Ul Hassan
Yaqoob Hassan
Prince Ajaz Ahmad
Omar Javed Shah
Mohamad Younis Bhat
Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley
Medical Journal of Babylon
pancreatoduodenectomy
aberrant right hepatic artery
surgical complication
postoperative pancreatic fistulas
oncological outcome
title Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley
title_full Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley
title_fullStr Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley
title_full_unstemmed Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley
title_short Hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy. A comparative study from Kashmir Valley
title_sort hepatic artery anomalies and its impact in patients undergoing pancreaticoduodenectmy a comparative study from kashmir valley
topic pancreatoduodenectomy
aberrant right hepatic artery
surgical complication
postoperative pancreatic fistulas
oncological outcome
url http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2022;volume=19;issue=3;spage=350;epage=353;aulast=Hassan
work_keys_str_mv AT nayeemulhassan hepaticarteryanomaliesanditsimpactinpatientsundergoingpancreaticoduodenectmyacomparativestudyfromkashmirvalley
AT yaqoobhassan hepaticarteryanomaliesanditsimpactinpatientsundergoingpancreaticoduodenectmyacomparativestudyfromkashmirvalley
AT princeajazahmad hepaticarteryanomaliesanditsimpactinpatientsundergoingpancreaticoduodenectmyacomparativestudyfromkashmirvalley
AT omarjavedshah hepaticarteryanomaliesanditsimpactinpatientsundergoingpancreaticoduodenectmyacomparativestudyfromkashmirvalley
AT mohamadyounisbhat hepaticarteryanomaliesanditsimpactinpatientsundergoingpancreaticoduodenectmyacomparativestudyfromkashmirvalley